STOCK TITAN

LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
LifeMD, Inc. to report Q1 2023 financial results on May 12th
Positive
  • LifeMD, Inc. will report its financial results for Q1 2023 before the market open on May 12th
Negative
  • None.

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market open on Friday, May 12, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time.

Conference Call & Webcast Details:
Date:Friday, May 12th
Time:8:30am ET
Toll Free:1-877-704-4453
International:1-201-389-0920 
Conference ID:13738585
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1613338&tp_key=c0937faa82

About LifeMD
LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Company Contact
LifeMD, Inc.
Marc Benathen, CFO
marc@lifemd.com


FAQ

When will LifeMD, Inc. report its Q1 2023 financial results?

LifeMD, Inc. will report its Q1 2023 financial results on May 12th.

What time will the conference call with investors take place?

The conference call with investors will take place at 8:30am Eastern Time.

What is the conference call and webcast details for LifeMD, Inc.?

The conference call and webcast details for LifeMD, Inc. are as follows: Date: Friday, May 12th; Time: 8:30am ET; Toll Free: 1-877-704-4453; International: 1-201-389-0920; Conference ID: 13738585; Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1613338&tp_key=c0937faa82

LifeMD, Inc.

NASDAQ:LFMD

LFMD Rankings

LFMD Latest News

LFMD Stock Data

217.41M
35.87M
15.71%
40.52%
13.55%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
NEW YORK